News Overview

The board has recommended a ₹2 per share dividend, which is now up for shareholder approval.

Bata India shares have dipped 16% in the last year, 12.96% in the year-to-date, and 2.60% dip in the last month. 

The IPO is being managed by Centrum Capital, Intensive Fiscal Services, and Motilal Oswal Investment Advisors as the book-running lead managers

The buyback will be carried out through the tender offer route, with the company planning to repurchase up to 20 lakh equity shares at a price of ₹875 per share.

Biocon has appointed Kotak Mahindra Capital, Goldman Sachs (India), and BofA Securities India as lead advisors for the transaction

The promoters have opted to pay a premium of ₹3.42 per warrant , a signal, many believe, of their long-term confidence in Zee’s strategic direction.

The company informed that it has received the order from South Central Railway for the deployment of the indigenous Kavach safety system.

The company said this deal fits into its larger strategy of expanding respiratory therapies beyond its home markets.

How were the key global and domestic signals at the start of the new week. Here is a quick dekko at 6 such signals.

Bharat Elec hits 52-week high in Nifty.